Ashley House PLC Sale of Pharmacy Interest to Repay Debt - Amended (8566E)
14 Février 2018 - 9:51AM
UK Regulatory
TIDMASH
RNS Number : 8566E
Ashley House PLC
14 February 2018
The following amendment has been made to the 'Sale of Pharmacy
Interest to Repay Debt' announcement released on 14/02/2018 at
07:00 under RNS No 7945E.
The second paragraph of the announcement should read: 'Invescare
Property Limited is a 100% subsidiary of Invescare Limited, a
privately owned company which is 24.4% owned by the Company's
Non-executive Deputy Chairman, Stephen Minion. The Asset is a
profit share arrangement that was entered into following the
development of a surgery and pharmacy in 2010 and is considered
non-core. The income received by the Company over the last four
quarters totalled GBP46,000. The agreed consideration for the sale
of the Company's interest in the Asset is GBP325,000. The
consideration will be satisfied by a reduction in the loan between
the Company and Invescare Limited.'
All other details remain unchanged. The full amended text is
shown below.
Ashley House plc
Sale of pharmacy interest to repay debt
Ashley House plc ("Ashley House" or the "Company"), the health
and community care property partner, is pleased to announce that it
has agreed to sell its 25% interest in a pharmacy located in London
(the "Asset") to Invescare Property Limited.
Invescare Property Limited is a 100% subsidiary of Invescare
Limited, a privately owned company which is 24.4% owned by the
Company's Non-executive Deputy Chairman, Stephen Minion. The Asset
is a profit share arrangement that was entered into following the
development of a surgery and pharmacy in 2010 and is considered
non-core. The income received by the Company over the last four
quarters totalled GBP46,000. The agreed consideration for the sale
of the Company's interest in the Asset is GBP325,000. The
consideration will be satisfied by a reduction in the loan between
the Company and Invescare Limited.
The transaction constitutes a related party transaction under
the AIM Rules due to Mr Minion's interest in Invescare Limited. The
Independent Directors, being the Directors other than Mr Minion,
consider, having consulted with WH Ireland, the Company's nominated
adviser, that the terms of the transaction are fair and reasonable
insofar as the Company's shareholders are concerned.
This announcement includes inside information as defined in
Article 7 of the Market Abuse Regulation No. 596/2014 and is
disclosed in accordance with the Company's obligations under
Article 17 of those Regulations.
Enquiries:
Ashley House plc 01628 600 340
Antony Walters
Jonathan Holmes
WH Ireland Ltd 0207 220 1666
(Nominated Adviser and broker to Ashley House plc)
Adrian Hadden
Ed Allsopp
James Sinclair-Ford
This information is provided by RNS
The company news service from the London Stock Exchange
END
DISVZLBFVLFZBBZ
(END) Dow Jones Newswires
February 14, 2018 03:51 ET (08:51 GMT)
Ashley House (LSE:ASH)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025
Ashley House (LSE:ASH)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025